Global excipient supplier has invested in the consolidation of multiple US legacy buildings into one unified manufacturing campus
Colorcon, a global excipient company, has completed a major expansion and renovation at its North America production facility in West Point, Pennsylvania.
The multimillion-dollar investment enhances the supply chain robustness for products manufactured and delivered to the makers of solid oral dosage products throughout the US, Canada, Puerto Rico, Mexico, Colombia, Peru, Bolivia and the northern areas of Central and Latin America.
Martti Hedman, Colorcon CEO, said: “Colorcon’s West Point site is one of seven film coating manufacturing sites strategically located around the world and is an important component in Colorcon’s Business Continuity Plan. This multi-year investment helps Colorcon to further improve its service to the customers and is a good example of how Colorcon invests in new capacity ahead of demand”.
Colorcon’s investment sees the consolidation of multiple legacy buildings into one unified, best-in-class manufacturing campus. The merging of these facilities provides customers with traceability on raw materials and finished goods and will meet and exceed the regulatory requirements of the FDA and other global regulatory and certification bodies.
There are also environmental benefits through the reduced transportation of materials between sites, reducing traffic in the area. And, with the upgrading of all air handling systems, there will be less environmental noise and more efficient use of the natural resources and utilities necessary to our production process.
Simon Tasker, President of the Americas region explained: “The investment in our West Point facility brings together expanded material warehousing and new best-in-class quality control laboratories to the existing production capabilities. This supports our future growth expectations, improves our environmental footprint and reduces supply lead times for our customers.”